BILL · 2005–06 SESSION
HB 1885: State investment board
Restricting the investment options of the Washington state investment board.
Summary
- Defines "pharmaceutical manufacturing company."
- Prohibits the Washington State Investment Board from investing in a pharmaceutical manufacturing company that: Restricts the supply of one or more prescription drugs to Canada in response to the reimportation of a prescription drug into the United States; or sells any of their prescription drugs in the United States at a rate that is more than 10 percent higher than the price they charge in Canada.
From the House Bill Analysis (HB 1885), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedFeb 9, 2005
- Out of committeestopped here
- Passed House
- Passed Senate
- Governor
- Law
- Prime sponsor
- Geoff Simpson (D-47)
- Introduced
- February 9, 2005 in the House
- Last action
- January 9, 2006
AN ACT Relating to investments by the Washington state investment board;
Sponsors
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- First reading, referred to Financial Institutions & Insurance.
HB 1885 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- HB 1885 (2025–26) Legislative privilege/PRA
- HB 1885 (2023–24) Campaign finance/foreign
- HB 1885 (2021–22) Dental therapy
- HB 1885 (2019–20) Election cert. & training
- HB 1885 (2017–18) Water resources/local gov.
- HB 1885 (2015–16) Property crimes, impacts of
- HB 1885 (2013–14) Nursing facility payment
- HB 1885 (2011–12) Natural environment programs